Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-17-026364
Filing Date
2017-04-26
Accepted
2017-04-26 16:13:29
Documents
5
Effectiveness Date
2017-04-26

Document Format Files

Seq Description Document Type Size
1 DEFA14A a17-11704_5defa14a.htm DEFA14A 33506
2 GRAPHIC g117045cai001.gif GRAPHIC 51912
3 GRAPHIC g117045cai002.gif GRAPHIC 96982
4 GRAPHIC g117045cai003.gif GRAPHIC 19346
5 GRAPHIC g117045cai004.gif GRAPHIC 4015
  Complete submission text file 0001104659-17-026364.txt   272251
Mailing Address 300 THIRD STREET FIRST FLOOR CAMBRIDGE MA 02142
Business Address 300 THIRD STREET FIRST FLOOR CAMBRIDGE MA 02142 617-401-9000
Editas Medicine, Inc. (Filer) CIK: 0001650664 (see all company filings)

IRS No.: 464097528 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37687 | Film No.: 17784500
SIC: 2836 Biological Products, (No Diagnostic Substances)